BIOWKS — Bio-Works Technologies AB Share Price
Last trade - 00:00- SEK100.18m
- SEK65.90m
- SEK25.47m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.25 | ||
| Price to Tang. Book | 2.25 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.93 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -85.22% | ||
| Return on Equity | -84.31% | ||
| Operating Margin | -149.21% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 7.23 | 21.91 | 41.32 | 43.9 | 25.46 | 153 | n/a | 35.51% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bio-Works Technologies AB is a Sweden-based biotechnology company. The Company designs, develops, manufactures and supplies products for purification and separation of proteins and other molecules for application in areas such as Research and Laboratory, Life Science and Biopharma, as well as Food and Beverage. The Company uses technology based on uses Agarose beads, which are derived from seaweed in the process of liquid chromatography and serve as adsorbers that bind molecules of interest allowing them to be recovered. Its product offerings, marketed under brand names WorkBeads, BabyBio and OptioBio, include Activated Resin for coupling ligands, BabyBio Columns for rapid protein purification and condition screening, Immobilized Metal-ion Affinity Chromatography (IMAC) Resin, Ion Exchange Chromatography (IEX) Resin and OptioBio Glass Columns for small-scale purification and screening, among others.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 26th, 2013
- Public Since
- December 14th, 2017
- No. of Shareholders
- 2,146
- No. of Employees
- 30
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- AktieTorget Stock Exchange
- Shares in Issue
- 77,959,580
- Address
- Virdings alle 18, UPPSALA, 754 50
- Web
- https://www.bio-works.com/
- Phone
- +46 856267430
- Auditors
- Ohrlings PricewaterhouseCoopers AB
Upcoming Events for BIOWKS
Similar to BIOWKS
Abera Bioscience AB
AktieTorget Stock Exchange
Aptahem AB
AktieTorget Stock Exchange
Carbiotix AB (publ)
AktieTorget Stock Exchange
Chosa Oncology AB
AktieTorget Stock Exchange
Curasight A/S
AktieTorget Stock Exchange
FAQ
As of Today at 19:36 UTC, shares in Bio-Works Technologies AB are trading at SEK1.29. This share price information is delayed by 15 minutes.
Shares in Bio-Works Technologies AB last closed at SEK1.29 and the price had moved by -39.91% over the past 365 days. In terms of relative price strength the Bio-Works Technologies AB share price has underperformed the FTSE Global All Cap Index by -41.41% over the past year.
The overall consensus recommendation for Bio-Works Technologies AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreBio-Works Technologies AB does not currently pay a dividend.
Bio-Works Technologies AB does not currently pay a dividend.
Bio-Works Technologies AB does not currently pay a dividend.
To buy shares in Bio-Works Technologies AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK1.29, shares in Bio-Works Technologies AB had a market capitalisation of SEK100.18m.
Here are the trading details for Bio-Works Technologies AB:
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: BIOWKS
Based on an overall assessment of its quality, value and momentum Bio-Works Technologies AB is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Bio-Works Technologies AB is SEK27.00. That is 2001.17% above the last closing price of SEK1.29.
Analysts covering Bio-Works Technologies AB currently have a consensus Earnings Per Share (EPS) forecast of SEK0.61 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bio-Works Technologies AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +56.52%.
As of the last closing price of SEK1.29, shares in Bio-Works Technologies AB were trading +8.38% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bio-Works Technologies AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK1.29.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Bio-Works Technologies AB's directors